# De-Escalation Radiotherapy in Patients With Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma

> **NCT03822897** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Canadian Cancer Trials Group** · enrollment: 103 (actual)

## Conditions studied

- Oropharyngeal Cancer

## Interventions

- **RADIATION:** Radiation
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT03822897
- **Lead sponsor:** Canadian Cancer Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-06-28
- **Primary completion:** 2024-06-25
- **Final completion:** 2026-12-31
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03822897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03822897, "De-Escalation Radiotherapy in Patients With Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT03822897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*